Results 161 to 170 of about 27,872 (237)

Japanese Encephalitis Vaccine Decision Aid for Travelers: A Randomized Clinical Trial.

JAMA Netw Open
McGuinness SL, Eades O, Morris J, Seale H, Cheng AC, Leder K.   +5 more
europepmc   +1 more source

A rare case of breakthrough tick-borne encephalitis in early adolescence after vaccination with four doses of TBE vaccine. [PDF]

New Microbes New Infect
Morgardt S, Veje M, Bergström T, Ivarsson L, Studahl M.   +4 more
europepmc   +1 more source

Evaluation of protective efficacy of an inactivated Japanese encephalitis virus genotype Ⅴ strain in mice. [PDF]

NPJ Vaccines
Lee JM, Kim SR, Ryou J, Choi JH, Shim SM.   +4 more
europepmc   +1 more source

Dual role of Japanese encephalitis virus fusion loop peptide antibodies in Zika virus infection. [PDF]

PLoS Negl Trop Dis
Xi K, Zhang X, Li J, Zhao Y, Xie X, Shen C, Zhang B, Zhu L, Xiao W, Wan C, Lin Y, Wang L, Liu Y, Wang Y, Yu J, Wu Q, Zhao W.   +16 more
europepmc   +1 more source

Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination. [PDF]

Hum Vaccin Immunother
Yuan J, Ding Y, Wang Z, Su L, Li K.
europepmc   +1 more source

Single nucleotide polymorphisms are typical for tick-borne encephalitis and West Nile viruses during triple natural mixed infections in Blyth's reed warbler (Acrocephalus dumetorum). [PDF]

Vavilovskii Zhurnal Genet Selektsii
Ponomareva EP, Ternovoi VA, Protopopova EV, Tupota NL, Loktev VB.   +4 more
europepmc   +1 more source

Consider autoimmune encephalitis in cases of headache, dizziness, and mild pleocytosis following SARS-CoV-2 infection. [PDF]

Neurol Res Pract
Zarrouk S, Finsterer J.
europepmc   +1 more source

THE VECTOR OF JAPANESE ENCEPHALITIS VIRUS

Uirusu, 1973
TAKAHASHI, Mitsuo, ISHII, Takashi, KAROJI, Yoshiaki   +2 more
openaire   +2 more sources

The Silent Spillover Threat: Nipah Virus Epidemiology, Pathogenesis, Clinical Manifestations, and Advances in Therapeutics and Vaccine Development. [PDF]

Microorganisms
Magklara EP, Kkirgia M, Tsantes AG, Ioannou P, Mpakosi A, Mougiou V, Iliodromiti Z, Boutsikou T, Iacovidou N, Sokou R.   +9 more
europepmc   +1 more source

Potential entry pathways for 25 vector-borne disease agents. [PDF]

EFSA J
European Food Safety Authority (EFSA), Dhollander S, Baltusyte I, Bigoni F, Broglia A, Figuerola J, Thulke HH, Chueca Miranda MA.   +7 more
europepmc   +1 more source